Back
Moleculin Biotech 10K Form
Sell
22
MBRX
Moleculin Biotech
Last Price:
$0.53
Seasonality Move:
-13.58%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MBRX News And Ratings
See the #1 stock for the next 7 days that we like better than MBRX
MBRX Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-4.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.00 |
| Price / Book: | 114.37 |
Profitability
| EPS (TTM): | -4.73000 |
|---|---|
| Net Income (TTM): | $-23.2M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Moleculin Biotech Earnings Forecast
Key Moleculin Biotech Financial Ratios
-
Per Share Earnings over the last 9 years have been positive in 6 years.
Moleculin Biotech Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MBRX |
| CUSIP: | 60855D |
| Website: | moleculin.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
MBRX Technical Analysis vs Fundamental Analysis
Sell
22
Moleculin Biotech (MBRX)
is a Sell
Is Moleculin Biotech a Buy or a Sell?
-
Moleculin Biotech stock is rated a SellThe current Moleculin Biotech [MBRX] share price is $0.34. The Score for MBRX is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.